NPI: 1659796233 · FORT WAYNE, IN 46809 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/19/2014
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 02/19/2014 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,736 | $24K |
| 2019 | 8,886 | $55K |
| 2020 | 11,296 | $106K |
| 2021 | 6,995 | $120K |
| 2022 | 8,345 | $151K |
| 2023 | 3,386 | $63K |
| 2024 | 148 | $1K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,549 | 1,862 | $494K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,017 | 368 | $26K |
| A4657 | Syringe, with or without needle, each | 1,288 | 537 | $198.64 |
| J1756 | Injection, iron sucrose, 1 mg | 309 | 60 | $171.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,690 | 164 | $122.92 |
| 82728 | 1,015 | 593 | $60.77 | |
| 83970 | 333 | 226 | $48.89 | |
| 83550 | 906 | 553 | $33.43 | |
| 83540 | 938 | 566 | $26.50 | |
| 85041 | 361 | 263 | $2.86 | |
| 85048 | 348 | 251 | $2.39 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 20 | 13 | $0.00 |
| 82108 | 18 | 13 | $0.00 |